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Histamine causes endothelial 
barrier disruption via Ca2+-
mediated RhoA activation and 
tension at adherens junctions
Daniela Kugelmann  , Lukas Thomas Rotkopf  , Mariya Yosifova Radeva,  
Alexander Garcia-Ponce, Elias Walter & Jens Waschke
During inflammation, the disruption of the endothelial barrier leads to increased microvascular 
permeability. Whether tension along cell junctions contributes to histamine-induced endothelial 
barrier disruption remains unknown. Rapid Ca2+ influx induced by both histamine and thrombin was 
accompanied by endothelial barrier breakdown revealed as drop of transendothelial electric resistance in 
primary human microvascular endothelial cells. Interestingly, GLISA measurements revealed activation 
of RhoA but not inactivation of Rac1 at the time-point of barrier breakdown. FRET measurements 
showed activation of RhoA at intercellular junctions after both thrombin and histamine exposure. 
Breakdown coincided with increased stress fiber formation but not with translocation of vinculin, which 
was located along junctions in the resting state similar to postcapillary venules ex vivo. Moreover, 
increased tension at AJs was indicated by immunostaining with a conformation-sensitive antibody 
targeting the α18-subunit of α-catenin. Ca2+ chelation by BAPTA-AM and ROCK1 inhibition by Y27632 
abolished both increase of tension along AJs as well as barrier dysfunction. Moreover, BAPTA-AM 
decreased RhoA activation following histamine stimulation, indicating a key role of Ca2+ signaling in 
barrier breakdown. Taken together, in response to histamine, Ca2+ via RhoA/ROCK activation along 
endothelial adherens junctions (AJs) appears to be critical for barrier disruption and presumably 
correlated with enhanced tension. However, vinculin appears not to be critical in this process.
The endothelium provides a selective barrier between the blood and the surrounding interstitial tissue providing 
nutrients to the tissues, regulating vascular homeostasis and the transmigration of leukocytes, preserving tissues 
through oncotic pressure control and participating in tumor neoangiogenesis and inflammatory reactions1–4. 
Endothelial cells are highly dynamic and are constantly subject to changes due to mechanical forces, and endothe-
lial cell junctions together with the glycocalyx form the endothelial barrier5. Within the intercellular contacts, 
tight junctions (TJs) directly limit paracellular permeability whereas adherens junctions (AJs) mechanically cou-
ple neighboring cells6. Both junction types are functionally linked with the cortical actin cytoskeleton through 
several adaptor molecules. Therefore, intracellular signaling affecting actin dynamics is essential in regulating 
endothelial barrier function7–10.
At the molecular level, AJs in endothelial cells are composed of vascular endothelial (VE-) cadherins, which 
allow for intercellular linkage with their extracellular domains in a Ca2+-dependent homophilic manner11. 
VE-cadherin is also crucial for endothelial barrier maintenance and recovery. The cytoplasmic domain of the 
VE-cadherin tail has binding sites for p120 catenin, which has been indicated to control VE-cadherin turno-
ver, lateral clustering and junction integrity8, as well as ß-catenin and y-catenin, which, subsequently bind to 
α-catenin, sequentially, linking the whole complex directly and/or indirectly via adaptor molecules to the actin 
cytoskeleton12–15. Cadherin complexes have been shown to not only transmit force but also act as active mech-
anosenors16. In this context, the adaptor protein vinculin, which anchors the cadherin complex via α-catenin to 
the actin cytoskeleton, is involved17–20. Vinculin interaction with AJ proteins protects VE-cadherin junctions from 
opening during their force-dependent remodeling16,21. One of the most potent signaling pathways for stabiliza-
tion of the barrier properties is regulation of actin dynamics through cyclic adenosine monophosphate (cAMP)7. 
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Furthermore, small GTPase family members, especially Rac1, Cdc24 and RhoA are crucial for regulation of the 
endothelial barrier3,5,7,22. Therefore, a fine balance between the activities of RhoA and Rac1 GTPases is required to 
maintain AJs23. Interestingly, we demonstrated in a former study that cAMP stabilizes the endothelial barrier via 
Rac1. Rac1 activation stabilizes the endothelial barrier against vasoactive stimuli in vitro and in vivo24,25, whereas 
RhoA has a diverse function in endothelial barrier regulation5,26.
RhoA effectively modulates the organization and dynamics of the actin cytoskeleton11. Furthermore, RhoA was 
found to induce the disassembly of endothelial AJs in response to inflammatory conditions23. Vasoactive media-
tors such as lipopolysaccharide (LPS) or tumor necrosis factor alpha (TNF-α) inhibit cAMP/Rac1 signaling and 
cause strong activation of RhoA5. RhoA activation leads to breakdown of the barrier, which is accompanied by 
the formation of gaps and stress fibers. This breakdown is caused by opening of interendothelial junctions in post-
capillary venules which results in severe subcutaneous and whole-body cavity edema3. Although considerable 
research interest in the mechanisms underlying barrier disruption is evident, the significance of tension generation 
during acute barrier breakdown is still unclear. In this study, we used the inflammatory mediator histamine, which 
has been shown to regulate endothelial properties through activation of the type I histamine receptor and Rho A 
signaling27,28, to study the mechanisms involved in anaphylaxis in primary human microvascular endothelial cells 
in vitro, and microvascular rat mesentery vessels in vivo. Here, we propose that histamine-mediated disruption 
of endothelial barrier function is Ca2+- and Rho kinase-dependent and correlates with enhanced tension at AJs.
Results
Histamine and thrombin induce AJ disruption and barrier dysfunction. Barrier function in 
endothelial cells is controlled by AJs and TJs, which are disrupted during pathological states29. To elucidate the 
time course under which endothelial monolayers react to the short-term vasoactive mediators, histamine and 
thrombin, immunofluorescence analysis of vascular endothelial cadherin (VE-cadherin), filamentous actin 
(F-actin), and vinculin was performed at several time points. After the addition of either histamine for 3, 10 and 
60 min or thrombin for 5 min, confluent HDMEC monolayers were fixed and stained for VE-cadherin (Fig. 1A) 
and labeled for F-actin using Alexa 488 phalloidin (Fig. 1B). Consistent with reports in the literature27, short-
term incubation with thrombin and histamine led to intercellular gaps- and increased stress fiber formation. 
Three minutes after histamine addition, intercellular gaps formed (Fig. 1A, arrows) and increased stress fiber 
formation was detected (Fig. 1B). Thrombin led to similar but stronger effects after 5 min of incubation. Ten 
minutes after histamine incubation, the intercellular gaps had largely closed. After 60 min of incubation, stress 
fiber formation was barely visible, and the intercellular gaps were no longer detectable (Fig. 1A–C). In contrast to 
control conditions, during the initial response, the linear formation of VE-cadherin at the intercellular membrane 
was disrupted and VE-cadherin distribution appeared a ragged (Fig. 1A). Furthermore, staining of vinculin and 
VE-cadherin in HDMECs under control conditions or after 3 min of histamine incubation (Fig. 1D–F) showed 
that vinculin staining was detectable on the cell membrane under both control and inflammatory conditions and 
that vinculin largely co-localized with VE-cadherin (Supplementary Fig. S1A).
In parallel, endothelial breakdown was detected by transendothelial electric resistance (TER) measure-
ments. For that purpose, HDMECs were grown to confluence and then incubated with histamine or thrombin. 
Histamine induced subtle and transient barrier dysfunction and basal resistance was significantly reduced to 
93.5% ± 0.8% after 0.5 min. Recovery to baseline was evident after 3.5 min. Then, TER continued to rise above 
control values, which were stable for the 60 min incubation period. In contrast, thrombin induced a stronger drop 
in TER (78.6% ± 3.7%), which recovered more slowly. In addition, specific inhibitors of histamine receptor type 
I, diphenhydramine (DPH) and histamine receptor type II, ranitidine (RAN) were preincubated with HDMECs 
for 15 min before the addition of histamine. As expected, diphenhydramine blocked the initial resistance drop 
whereas ranitidine had no significant effect (Fig. 1G,H).
Increased α18-catenin staining indicates higher tension along AJs during the initial histamine 
response. A conformation-sensitive antibody targeting the α18-subunit of α-catenin (α18-catenin) was 
used. It has been described that antibody binding correlates with tension at AJ because the epitope it binds to, is 
exposed during tension30. Morphologically, stronger but discontinuous staining of α18-catenin primarily along 
cell borders was detectable after 3 min of histamine incubation compared to control (Fig. 2A). Staining of vinculin 
at the cell border was observed under control conditions and colocalization with α18-catenin did not differ signif-
icantly after addition of histamine (Fig. 2B, Supplementary Fig. S1B). Quantifications of the relative fluorescence 
intensity revealed that the mean changes in α18-catenin-staining after histamine addition were 201.1% ± 10.0%, 
152.9% ± 15.6% and 114.3% ± 22.4% of control, after 3, 10 and 60 min, respectively, whereas thrombin increased 
α18-catenin-staining by 189.7% ± 9.2% at the border (Fig. 2D) but not in the cytoplasm (Fig. 2E). In contrast, 
the fluorescence intensity of vinculin did not significantly change at the cell borders or cytoplasm (Fig. 2D,E). In 
addition, histamine transiently induced a dotted staining pattern resembling focal adhesions which was reflected 
in a not significant increase of vinculin staining intensity in the cytoplasm and which was also detectable follow-
ing treatment with thrombin.
Activation of Rho GTPases and Ca2+ influx under inflammatory conditions. The ability of 
endothelial cells to contract involves myosin light chain phosphorylation via myosin light chain kinase (MLCK) 
and Rho family proteins31. Of these, RhoA and Rac1 have been reported to play major roles in the short-term 
inflammation response26,27,32. Intracellular GTP-bound Rac1 or RhoA levels were measured by GLISA after the 
addition of either thrombin or histamine following a standard protocol. GLISA measurements revealed signif-
icant activation of RhoA to 232.4% ± 17.9% of control after incubation with histamine for 3 min (Fig. 3A) and 
421.8% ± 33.4% after 5 min of thrombin treatment (Fig. 3B). There were no significant changes after either incu-
bation of histamine for 10 min or 60 min as well as thrombin for 60 min (Fig. 3A,B). Under the same conditions, 
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no significant changes in Rac1 activity were detected (Fig. 3C,D). As cAMP levels allegedly contribute to barrier 
breakdown and recovery20,33, intracellular cAMP levels were measured by ELISA. However, no significant changes 
in cAMP concentrations were detected during the course of barrier breakdown and recovery (Fig. 3G).
Figure 1. Changes in endothelial morphology and barrier integrity induced by inflammatory mediators. 
Confluent HDMEC monolayers were incubated with either histamine or thrombin and subsequently fixed 
with PFA (representative images of n = 4 independent experiments). (A–C) Immunostaining against VE-
cadherin and F-actin. Histamine and thrombin induced gap formation as indicated by VE-cadherin staining 
(arrows) and increased stress fiber formation after 3 and 5 min, respectively. At 60 min, stress fiber formation 
was largely abolished. (D–F) Co-staining for VE-cadherin and vinculin under control conditions and after 
incubation with histamine for 3 min. Vinculin was visible at the membrane under both conditions, however gap 
formation was present only upon histamine treatment (arrow). (G) TER measurements in confluent HDMECs 
after histamine or thrombin stimulation with or without pre-incubation with diphenhydramine (DPH) or 
ranitidine (RAN) for 60 min (n = 4 independent experiments, *p < 0.05, dotted line indicates application 
of mediators). (H) Quantification of minimal resistance during the initial drop showed decreases in basal 
resistance to 93.5% ± 0.8% (histamine) and 78.6% ± 3.7% (thrombin). Pre-incubation with DPH reduced the 
drop significantly to 98.6% ± 0.9% whereas pre-incubation with RAN had no significant effect.
www.nature.com/scientificreports/
4SCIentIfIC REPORTS |  (2018) 8:13229  | DOI:10.1038/s41598-018-31408-3
After activation of the histamine type 1 receptor, downstream activation of PLC-ß leads to increased intracellu-
lar Ca2+ concentrations, subsequently activating a cascade of signaling molecules23,34,35. Ratiometric FURA meas-
urements36 were used to determine the Ca2+-concentration in HDMEC monolayers after histamine or thrombin 
stimulation. Both mediators lead to a strong Ca2+ influx that correlated with force production. Preincubation with 
DPH abrogated this influx, whereas the histamine type 2 receptor inhibitor RAN did not (Fig. 3E,F).
Histamine and thrombin cause activation of RhoA along cell junctions. To further investigate 
the signaling patterns involved in histamine-induced inflammation, we used fluorescence resonance energy 
probes to elucidate the subcellular localization of GTP-bound RhoA32. Primary microvascular endothelial cells 
(HDMEC) were transfected with Raichu-RhoA plasmid and allowed 24 h of rest for stable expression of the 
Förster Resonance Energy Transfer (FRET) probes. Under basal conditions, the probe localized primarily to the 
membrane, but was also detectable throughout the cytosol (Fig. 4A). Consistent with the GLISA experiments, 
in the whole cell histamine and thrombin both increased the absolute FRET efficiency to 263.8% ± 29.5% and 
262.0% ± 19.3% of control after 3 and 5 min, respectively (Fig. 4B). Furthermore, RhoA activity at the membrane 
was measured by averaging the FRET efficiency over the outermost ten pixels of the cell (Fig. 4C). We detected 
activation to 263.1% ± 30.0% and 252.2% ± 23.0% of control at the cell border after addition of histamine and 
thrombin, respectively. At the 10 and 60 min time points of histamine treatment, FRET efficiency no longer dif-
fered significantly from control.
Figure 2. α18-catenin staining along AJs. (A–C) Staining with antibodies against α18-catenin and vinculin 
after the addition of histamine or thrombin at different time-points. (D) Automated quantification of the 
fluorescence intensity at the cell border after staining with α18-catenin or vinculin using CellProfiler. Intensity 
of α18-catenin staining increased significantly 3 and 5 min after addition of histamine or thrombin, respectively 
(n = 4 independent experiments, *p < 0.05). At these time points intensity of vinculin staining did not change 
significantly at the membrane. (n = 4 independent experiments, *p < 0.05) The relative fluorescent intensity of 
vinculin in the cytoplasm was slightly increased upon thrombin and histamine treatment while under the same 
conditions α18-catenin was unaltered. (n = 4 independent experiments, *p < 0.05).
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Figure 3. Signaling pathways activated during histamine-mediated barrier disruption. (A,B) RhoGTPase 
ELISA (GLISA) measurements of HDMECs after incubation with histamine or thrombin at different time 
points. In comparison to the control, RhoA activity increased significantly 3 and 5 min after addition of 
histamine or thrombin, respectively (n = 4 independent experiments, *p < 0.05). (C,D) No changes of Rac1 
activity, measured by GLISA, were observed upon different treatments (n = 3 independent experiments, 
*p < 0.05). (E) Fluorescence intensity measurements of FURA-2-AM revealed a significant increase in 
intracellular Ca2+concentration following histamine stimulation. Pre-incubation with DPH but not RAN 
completely abolished Ca2+ influx (n = 5 independent experiments, *p < 0.05, dotted line indicates histamine 
application). (F) FURA-2-AM measurements after thrombin stimulation showed a similar burst in intracellular 
Ca2+ levels (n = 4 independent experiments, *p < 0.05, dotted line indicates addition of thrombin). (G) 
Measurement of intracellular cAMP concentration after histamine treatment revealed no significant change of 
cAMP levels (n = 4,*p < 0.05).
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Inhibition of ROCK and Ca2+ -signaling reduces histamine-induced barrier dysfunction and 
α18-catenin staining. Downstream of histamine receptor activation, intracellular Ca2+ -signaling and Rho 
Kinase (ROCK) activation contribute to endothelial barrier dysfunction27,28. Y27632, a specific inhibitor of ROCK 
I and ROCK II and BAPTA-AM, an intracellular Ca2+-chelator, were used to suppress these pathways. Primary 
microvascular endothelial cells were preincubated with Y27632 or BAPTA-AM before histamine or thrombin 
addition and stained for VE-cadherin and F-actin (Fig. 5A–C, Supplementary Fig. S2A–C). Both Ca2+-chelation 
and ROCK inhibition prevented AJ disruption. Interestingly, BAPTA-AM effectively abrogated stress fiber for-
mation whereas Y27632 did not, suggesting that Ca2+-dependent and Rho-independent pathways may also be 
involved. The results were confirmed by TER measurements (Fig. 5D). The drop in TER after the addition of 
histamine was inhibited by incubation with both BAPTA-AM (maximum drop 99.4% ± 0.3% of baseline) and 
Y27632 (maximum drop 98.1% ± 1. 8%) (Fig. 5E). However, GLISA experiments showed that preincubation 
with BAPTA-AM significantly reduced RhoA activation in response to histamine to 127.9% ± 14.4% of control 
compared to 197.2% ± 24.06% after incubation with histamine alone for 3 min, suggesting that Ca2+ -signaling is 
required for full activation of RhoA (Fig. 5F).
Next, we studied the effect of ROCK inhibition and Ca2+-signaling on α18-catenin staining intensity along 
cell borders (Fig. 6A). The mean relative intensity in α18-catenin staining at cell borders after histamine incu-
bation (161.2% ± 18.5%) was reduced by preincubation with Y27632 (106.2% ± 18.2%) and BAPTA-AM 
(99.6% ± 19.7%) (Fig. 6D). Notably, the intensity of vinculin staining at junctions as well as colocalization with 
α18-catenin did not change significantly (Fig. 6B,D,E, Supplementary Fig. S1C). In addition, similar to Fig. 2 
histamine induced a dotted staining pattern of vinculin resembling focal adhesions which was reflected in an 
inconsistent but not significant increase of vinculin staining intensity in the cytoplasm and also was abrogated by 
and BAPTA-AM.
Histamine disrupts actin and vinculin localization along endothelial membranes in vivo. To 
test whether the aforementioned effects of histamine also occur in vivo, the experimental conditions were repli-
cated in a rat model. We used the modified Landis technique1, in which a single postcapillary venule of rat mes-
entery was cannulated with a glass capillary and continuously perfused with ringer solution containing BSA to 
dilute erythrocytes to visualize flow. After 5 min of perfusion with either control or histamine-containing solution 
the rat was euthanized, and the mesentery was immediately fixed with formaldehyde. The injected and marked 
venules were immunostained for vinculin together with F-actin labeling. Unfortunately, α18-catenin staining was 
not feasible since the antibodies origin is rat. Of note, parallel experiments using thrombin were not possible since 
it is known that intact mesenteric venules do not respond to thrombin37,38. Under control conditions, we observed 
Figure 4. Histamine and thrombin induce activation of RhoA at cell borders. Acceptor-photobleaching FRET 
efficiency in HDMECs transfected with Raichu-RhoA probes and treated with either histamine or thrombin. 
(A) Pseudocolor representation of the absolute FRET efficiency showed localization of active RhoA in the 
whole cell (representative images of n = 5 independent experiments). (B,C) The mean absolute FRET efficiency 
quantified over the whole cell and cell borders using CellProfiler (n = 5 independent experiments, *p < 0.05). 
Incubation with thrombin (5 min) and histamine (3 min) significantly increased RhoA activity in the whole cell 
as well as at the cell border. (n = 5 independent experiments, *p < 0.05).
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colocalization of actin and vinculin along the endothelial cell membranes (Fig. 7). Endothelial cell borders were 
smooth and parallel to the flow direction. After perfusion with histamine for 5 min, vinculin staining alongside 
the endothelial cell borders changed to a more ragged appearance (Fig. 7A–C). These results indicate that similar 
to primary cultured endothelium, vinculin was present at cell borders under resting conditions. Upon histamine 
treatment, we observed a trend towards lower colocalization of vinculin and filamentous actin as measured by 
Pearsons’ correlation coefficient, which however was not significant (Fig. 7D).
Figure 5. Inhibition of ROCK and Ca2+ signaling reduces histamine-induced barrier dysfunction. (A–C) 
Staining of HDMEC monolayers against VE-cadherin and F-actin after stimulation with histamine alone or 
after pre-incubation with either Y27632 (30 min) or BAPTA-AM (2 h). The gaps (arrows) induced by histamine 
(3 min) were largely abolished by application of either Y27632 or BAPTA-AM (n = 4 independent experiments). 
(D,E) TER measurements showed that the initial drop in resistance, induced by histamine, was significantly 
abolished by pre-incubation with both mediators (n = 3 independent experiments, *p < 0.05). (F) RhoA GLISA 
measurements in HDMECs revealed that BAPTA-AM reduces RhoA activation after histamine stimulation. 
(n = 3 independent experiments, *p < 0.05 vs control).
www.nature.com/scientificreports/
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Discussion
Histamine induces a transient decrease in barrier function accompanied by increased α18-cat-
enin staining along AJs. The signaling mechanisms underlying acute endothelial barrier breakdown under 
inflammatory conditions are not entirely clear. Histamine and thrombin induce acute break-down of the endothe-
lial barrier. However, thrombin is not a typical inflammatory mediator since it regulates vascular permeability 
during the coagulation phase after injury39 and in many studies macrovascular endothelial cells were used, which 
are good models for investigating adaptations to sheer stress but not the inflammatory response, which occurs 
exclusively in postcapillary venules3. Therefore, re-evaluation of all findings using microvascular endothelium is 
necessary. Histamine impaired the integrity of the endothelial barrier in vitro and in vivo23,40–42. The mechanism 
by which histamine leads to the disruption of the endothelial barrier is not fully understood, however, H1R Gαq-
coupled receptors27,42,43 and PCK-, RhoA/ROCK- and NO-signaling seem to be important. In addition, histamine 
has been proposed to disrupt AJs, leading to the rapid formation of a new junction type referred to as focal adhe-
rens junction (FAJ), which is characterized by recruitment of vinculin16.
In this study, we used histamine to study barrier disruption and the corresponding signaling pathways involved 
in anaphylaxis in primary human microvascular endothelial cells in vitro and postcapillary venules of rat mesentery 
in vivo. Thrombin was used in comparison in vitro only because intact mesenteric venules do not respond to throm-
bin37,38. Consistent with the literature42, our data showed that histamine and thrombin disrupted the endothelial 
barrier transiently and caused reduced TER and intercellular gap formation. At the same time, both thrombin and 
Figure 6. Increased α18-catenin staining along AJ is dependent on ROCK and intercellular Ca2+ signaling. 
(A–D) In HDMECs co-staining against α18-catenin and vinculin revealed a marked increase in α18-catenin 
staining intensity at cell borders following histamine incubation (3 min). However, this was not the case after 
pre-incubation with Y27632 or BAPTA-AM (n = 3 independent experiments). (D,E) Bar graph showing 
automated quantification of vinculin and α18-catenin fluorescence intensity at cell border and in the cytoplasm. 
Vinculin staining showed no significant change in localization or intensity after pre-incubation with Y27632 or 
BAPTA-AM. (n = 3 independent experiments, *p < 0.05).
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histamine enhanced staining with the conformation-sensitive antibody targeting the alpha 18-subunit of catenin 
which has been proposed to correlate with increased tension at AJs (Fig. 8). Increased tension may result from 
RhoA-dependent up-regulation of actomyosin contraction27 which may trigger relocalization of vinculin to AJs 
from FAJs16. Therefore, we correlated the different events during endothelial barrier breakdown with immunostain-
ing for vinculin, which is known to be a mechanotransducer with the ability to stabilize adhesion under force16,44–46. 
Interestingly, we observed that vinculin was localized at cell junctions under resting conditions both in HDMECs 
in vitro and endothelial cells of postcapillary venules in vivo. Moreover, after incubation with either histamine or 
thrombin, vinculin distribution paralleled VE-cadherin and F-actin localization. AJs similar to vinculin were reor-
ganized from continuous linear distribution towards a fragmented staining pattern with perpendicular arrays which 
were previously described as FAJ. However, the staining intensity for vinculin remained unaffected. These data indi-
cate that in microvascular endothelium, vinculin is a normal constituent of AJs under resting conditions (Fig. 8) and 
that the term FAJ may not be adequate in this cell type. The discrepancy to the previous study16 may be explained 
at least in part by the fact that most experiments in the previous study were shown for HUVECs which is a macro-
vascular endothelial cell type from fetal tissue and therefore is not derived from the typical vascular bed to study the 
inflammatory response. Moreover, the confluency of the endothelium, which was maximal under the conditions 
used for our study, may also have been different. The fact that the microvascular human HDMEC cells exhibited 
vinculin localization along cell borders similar to endothelial cells of intact post-capillary venules indicates that the 
conditions used here were appropriate to study endothelial barrier regulation.
RhoA is activated along intercellular junctions whereas no significant change in Rac1 activity or 
cAMP levels were detected. Thrombin can increase endothelial permeability by activating Ca2+ -/RhoA- 
signaling, which disrupts endothelial adherens junctions47. Similarly, several studies have shown the importance 
of RhoA signalling in histamine-induced leakage. Most recently, RhoA-deficient animals were protected against 
histamine-induced vascular permeability26,47. Our results support this notion (Fig. 8) since inhibition of ROCK 
effectively blocked histamine-induced barrier breakdown. However, how RhoA signaling induces the disruption 
of the endothelial barrier is less well defined. Because activation of RhoA GTPase is spatiotemporally controlled26 
and overall activation as shown by GLISA may not accurately reflect activation at the site of cell junctions, we 
used Rho GTPase FRET sensors to visualize activation with high temporal and spatial resolution. These sensors 
change conformation and subsequent FRET efficiency depending on the local balance of guanine nucleotide 
exchange factors (GEFs) and GTPase-activating proteins (GAPs). Our data confirm that treatment with both 
thrombin or histamine induced activation of RhoA in the cytoplasm and also along cell borders. This is in line 
with the idea that RhoA has an important role in the regulation of endothelial barrier properties after treatment 
with inflammatory mediators.
Figure 7. Ex-vivo immunostaining of single-perfused rat postcapillary venules demonstrate disruption of 
vinculin staining along the membrane after histamine stimulation. (A) In postcapillary venules actin forms 
longitudinal fiber bundles. (B) Endothelial cells display vinculin staining under resting conditions while 
the staining along cell borders is disturbed after stimulation with histamine (arrow). (C) Overlay of F-actin 
and vinculin staining (n = 4 independent experiments). (D) Co-localization between vinculin and actin, 
determined by Pearsons correlation coefficient, appears to be slightly reduced due to histamine treatment (n = 4 
independent experiments).
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In addition, it is well established that activated small GTPase Rac1 and the second messenger cAMP stabi-
lize endothelial barrier properties48. For LPS and TNF-α, it has been shown that endothelial barrier breakdown 
temporally was closely associated with both decreased cAMP levels and Rac1 inactivation whereas RhoA activa-
tion was observed later48,49. Moreover, CNF-1 under conditions where it activated Rac1 and RhoA in parallel in 
cultured endothelium was effective to abrogate TNF-α-induced barrier breakdown in mesenteric post-capillary 
venules in vivo whereas Rho kinase inhibition was not. These observations suggest that inactivation of Rac1 rather 
than stimulation of the RhoA/Rho kinase pathway was the primary mechanism underlying TNF-α-mediated 
permeability increase.
Surprisingly, our results of the present study showed no differences in Rac1 activity or in cAMP concentra-
tions after treatment with histamine. Therefore, we conclude that in contrast to the situation in sepsis, where LPS 
and TNF-α are relevant, alterations of cAMP levels as well as Rac1 activity are less important in anaphylaxis. 
Rather, acute inflammation appears to be primarily dependent on Ca2+ and activation of RhoA.
Ca2+ signaling is required for RhoA activation, AJ reorganization and barrier dysfunction. 
Permeability mediators, including histamine, act on Gαq-coupled GPCRs leading the activation of PLC-ß and the 
rapid mobilization of Ca2+, which promotes MLC phosphorylation and the stimulation of its contractile activ-
ity27. RhoA can be activated independently by H1R coupled to Gq/1128. H1R also leads to an increase of intracellu-
lar Ca2+ concentration. As reported previousley28, we found that H1 receptor is required for histamine to induce 
permeability (Fig. 8). Our results revealed that both histamine and thrombin lead to a rapid Ca2+-influx accom-
panied by parallel reduction of TER. Chelation of Ca2+ by BAPTA-AM similar to inhibition of ROCK blocked the 
effects of histamine and thrombin on barrier function and AJ reorganization. Moreover, BAPTA-AM prevented 
activation of RhoA and similar to inhibition of ROCK blunted α18-catenin staining along junctions. These results 
indicate that Ca2+ -mediated RhoA activation is critical for endothelial barrier regulation (Fig. 8). The pivotal 
role of RhoA has been demonstrated previously27, however, in this study the authors concluded that RhoA was 
activated primarily independent of Ca2+. In addition, we observed that stress fiber formation in response to 
histamine was abrogated by chelation of Ca2+ but not by inhibition of Rho kinase. This supports the notion that 
in response to histamine stress fiber formation can be induced by Ca2+ in a manner independent of Rho kinase, 
most likely via MLCK50, and suggests that stress fibers are not directly involved in tension formation at AJ and 
endothelial barrier breakdown (Fig. 8).
Figure 8. Mechanisms of histamine-induced endothelial barrier disruption. Under resting conditions, vinculin 
is localized mainly along endothelial cell borders and at least in part co-localizes with VE-cadherin and 
α-catenin at AJs. In anaphylaxis, histamine induces a rapid increase of cytoplasmic Ca2+ leading to activation 
of RhoA. Both events induce stress fiber formation at focal adhesions. In addition, RhoA via Rho kinase may 
enhance tension on α-catenin at endothelial AJs which causes AJ reorganization. H1R = Histamine receptor 
type I; Ca2+ = calcium; MLC = myosin light chain; FAK = focal adhesion kinase; VASP = vasodilator-stimulated 
phosphoprotein; ZO-1 = zonula occludens protein1; α, β, γ = α-, β-, γ-catenin; ECM = extracellular matrix.
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Conclusion
Therefore, we conclude that Ca2+ via RhoA/ROCK activation is critical for histamine-induced barrier disrup-
tion which correlated with tension-associated α18-catenin staining along endothelial AJ. These data suggests that 
the patterns of signaling mechanisms engaged in acute inflammatory barrier disruption differ to more delayed 
responses as seen in sepsis where reduction of endothelial cAMP and inactivation of Rac1 appears to be more rele-
vant5. Furthermore, Rho-mediated tension may be involved in acute endothelial barrier disruption, at least in vitro.
Methods
Cell Culture and antibodies. All experiments were performed using Human Dermal Microvascular 
Endothelial Cells (HDMEC) (Promocell, Heidelberg, Germany). Cells were maintained in corresponding medium 
(Endothelial Cell Growth Medium MV; Promocell, Heidelberg, Germany) and used at passages between three and 
six. Vascular endothelial (VE-) cadherin was detected using goat-anti-VE-cadherin antibody purchased from Santa 
Cruz Biotechnology (Santa Cruz, USA). Vinculin was immunostained using mouse-pc-anti-vinculin antibody 
purchased from Abcam (Cambridge, UK). Rat α18-catenin antibody was contributed from Yonemura S. (RIKEN 
Center for Developmental Biology, Kobe,Jyogo, Japan)30. Filamentous actin (F-actin) was illuminated using an 
Alexa 488 phalloidin dye (Life Technologies, Karlsruhe, Germany). The addition of 4′,6′-diamidino-2-phenylin-
dole (DAPI) was used to assess nuclear morphology. Corresponding secondary antibodies were purchased from 
Dianova (Hamburg, Germany) and were also used for control experiments (Supplementary Fig. S3).
Test Reagents. Histamine and thrombin were purchased from Sigma-Aldrich (Munich, Germany). 
Histamine was used at 10 µM for the indicated times and thrombin was used at 10 U for 5 min. BAPTA-AM 
(Sigma-Aldrich, Germany) was preincubated for two hours at 5 µM. Diphenhydramine was used to inhibit acti-
vation of histamine receptor type I, and ranitidine was used for inhibition of histamine receptor type II. Both 
were preincubated at 1 µM and 10 µM, respectively, for 15 min. The ROCK inhibitor Y27632 (Sigma-Aldrich, 
Germany) was preincubated for 30 min at 10 µM.
Transendothelial Electric Resistance Measurements. The barrier integrity of HDMECs was meas-
ured using an ECIS Z Theta system (Applied Biophysics, New York, U.S.A). HDMEC monolayers were grown to 
confluence on uncoated 8W10E electrodes. Immediately before the experiment, the medium was exchanged and 
the electrode was mounted on a holder inside an incubator at 37 °C with 5% CO2. Transendothelial resistance was 
measured at 4000 Hz every 10 seconds. Test reagents were diluted in pre-warmed medium. After recording 5 min 
of baseline values, the mediators were added.
Immunostaining. HDMECs were grown to confluence on uncoated glass cover slips, treated with vehicle or 
test reagents and fixed with 4% formaldehyde in PBS for 10 min at room temperature. After washing and permea-
bilization using 0.1% Triton X-100 in PBS, the cells were blocked with 10% normal goat or donkey serum and 1% 
BSA in PBS. The respective primary antibody was incubated overnight at 1:100 in PBS at 4 °C. After washing, cells 
were treated with respective secondary antibodies coupled to Cy2, Cy3 or Cy5 for one hour and then embedded 
in n-propyl gallate. F-actin was stained using an Alexa 488 phalloidin dye added to the diluted secondary anti-
body at 1:100. Using the fixation protocol described above, patterns of actin filaments under control conditions 
resembled those observed in previous studies49,51,52. However, we cannot guarantee that all peripheral filaments 
were preserved when compared to an unfixed state, which we believe is not important for this study.
Stained monolayers were sequentially illuminated using a Leica SP5 confocal microscope (Mannheim, 
Germany) with an HCY PL APO Lambda blue 63 × 1.4 oil immersion objective and a zoom of 2x. Cy3 was illu-
minated with a wavelength of 542 nm and Cy5 with 633 nm. The same microscope settings were used under all 
conditions. Secondary antibody controls were performed for all co-immunostainings (Supplementary Fig. S3).
To calculate the Pearson’s correlation coefficient confocal images were analysed using Image Processing and 
Analysis in Java´s (Image J) segmented line and plot profile tools. A line (110 pixels length, 2 pixels width) was 
drawn along cell borders based either on F-actin or vinculin distribution. Subsequently, plot profiles were gener-
ated using the built-in tool. Pixel gray values for both proteins of interest obtained from these plots were trans-
ferred to Excel and used for calculations of the Pearson’s correlation coefficient.
G-Protein ELISA (GLISA)/cAMP-ELISA. Intracellular concentrations of GTP-bound Rac1 and RhoA pro-
teins were determined using commercially available ELISA kits purchased from Cytoskeleton (Denver, U.S.A). 
The assay was performed according to the manufacturer’s instructions. The technique was used as described 
previously33, cAMP concentrations were measured by cAMP enzyme linked immunosorbent assay (CA-200) 
(Sigma-Aldrich, St. Louis, U.S.A.) as described previously53.
Fluorescence Resonance Energy Transfer (FRET). Spatiotemporal activation of RhoA was deter-
mined using a RhoA-Ras and interacting protein chimeric unit (Raichu) –probe (a kind gift of Miyazaki J., Kyoto 
University, Japan)54,55 consisisting of four modules: a donor (CFP), an acceptor (YFP), a Rho binding domain 
(RBD) and the Rho GTPase itself. Upon exchange of GDP to GTP, the RBD binds the GTP-RhoA complex and 
the distance between the donor and acceptor decreases, increasing the energy transfer from the donor to an 
acceptor when illuminated at donor excitation wavelength. The RhoA-Raichu probe is contained in a transfecta-
ble plasmid. The plasmid was transfected with jetPRIME (VWR) into HDMECs at 80% confluence, grown to a 
confluent monolayer and then subjected to FRET-measurements. After the addition of mediators, the cells were 
fixed using 4% PFA in PBS for 20 min. Using standard acceptor photobleaching protocol56, YFP was bleached for 
3 min at 514 nm and CFP intensity was recorded before and after bleaching. Processing was performed in ImageJ 
and absolute FRET efficiency values were recorded.
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FURA-2 AM Measurements. Intracellular Ca2+ concentrations were detected by radiometric analysis of 
FURA-2-AM (Thermo-Fisher, Massachusetts, USA). Cells were incubated in FURA-containing medium for 
45 min, and then the medium was exchanged. After a 15 min rest period to allow cleavage of the ester, the cells 
were illuminated every 3 seconds and the signal was detected at 340 nm/380 nm. After 20 seconds of baseline 
detection, reagents were added.
Microperfusion of rat venules. We perfused single postcapillary venules in the rat mesentery using the 
modified Landis technique3,57,58. Wistar rats (provided from Janvier Labs, Saint-Berhevin Cedex) with body 
weights between 280 g and 350 g were anesthetized by subcutaneous injection of ketamine (60.0–75.0 mg/kg) and 
medetomidine (0.25–0.5 mg/kg). Then small unbranched microvessels with convergent flow were cannulated 
using sharp glass micropipettes and perfused continuously with mammalian ringer solution containing 10 mg/
ml bovine serum albumin (BSA) with or without 10 µm/l histamine dihydrochloride. Further addition of diluted 
erythrocyte concentrate allowed visualization of correct placement and flow. After 5 min of perfusion, the rats 
were euthanized and the intact mesentery was washed and fixed immediately in 4% formaldehyde in PBS. The 
mesentery was then spread on adhesive glass slides, permeabilized with 0.1% Triton in PBS and blocked using 
BSA/NDS. Further immunostaining for VE-cadherin, vinculin and F-actin was performed as described above. 
Illumination was performed by taking z-stacks with a confocal microscope (Leica SP5 confocal microscope) 
using a 63 × 1.4 water immersion objective. All rats were kept under conditions that conformed to the regulations 
of the Regierung von Oberbayern and all experiments were performed in accordance with relevant guidelines and 
regulations. The experimental protocol was approved by the Regierung von Oberbayern.
Statistics. Immunofluorescence experiments were quantified using CellProfiler (CarpenterLab, Cambridge, 
USA). After background subtraction, cell borders were segmented and the mean fluorescence intensity 
recorded59. For automated measurements of fluorescence intensity in the cytosol, the area of the segmented cell 
borders was subtracted from each image and mean intensity was calculated. The data analysis was carried out 
using R60 (R Foundation, Vienna, Austria) and OriginPro 2017 g (OriginLab Corporation, Northampton, USA). 
Statistical analysis was carried out using one-way ANOVA followed by Holm–Bonferroni corrections for multi-
ple comparisons. All data are presented as the mean ± standard error of the mean. The results were considered 
statistically significant at p < 0.05.
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